NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

23 hedge funds and large institutions have $139K invested in Navidea Biopharmaceuticals Inc. in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 12 closing their positions.

Holders
23
Holders Change
-7
Holders Change %
-23.33%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
3
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
State Street
1
State Street
Massachusetts
$38K
2
ACM
2
Allred Capital Management
Texas
$27K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$11.6K
4
BFM
4
Boothbay Fund Management
New York
$3.68K
5
TSS
5
Two Sigma Securities
New York
$5.46K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
2
Millennium Management
2
Millennium Management
New York
$0
3
BCM
3
Bridgeway Capital Management
Texas
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
WAM
5
Warberg Asset Management
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BCM
26
Bridgeway Capital Management
Texas
– -$26.6K -102,440 Closed
Citadel Advisors
27
Citadel Advisors
Florida
– -$17.1K -65,807 Closed
Simplex Trading
28
Simplex Trading
Illinois
– -$7K -28,416 Closed
WAM
29
Warberg Asset Management
Illinois
– -$7.29K -28,026 Closed
VF
30
Virtu Financial
New York
– -$4K -16,301 Closed
Wolverine Trading
31
Wolverine Trading
Illinois
– -$5K -16,297 Closed
Fidelity Investments
32
Fidelity Investments
Massachusetts
– -$260 -1,000 Closed
ASN
33
Advisory Services Network
Georgia
– -$65 -250 Closed
CTB
34
Country Trust Bank
Illinois
– -$2 -7 Closed
1
2